41.
Simvastatin is associated with reduced risk of acute pancreatitis: findings from a regional integrated healthcare system
by Wu, Bechien U
Gut, 2015-01, Vol.64 (1), p.133-138
42.
Commentary: simvastatin as the key to improving H. pylori eradication rates? Authors' reply
by Nseir, W
Alimentary pharmacology & therapeutics, 2012-09-01, Vol.36 (6), p.494
43.
Commentary: simvastatin as the key to improving H. pylori eradication rates?
by den Hollander, W. J
Alimentary pharmacology & therapeutics, 2012-09-01, Vol.36 (6), p.493
44.
Evaluating cardiovascular event reduction with ezetimibe as an adjunct to simvastatin in 18,144 patients after acute coronary syndromes: Final baseline characteristics of the IMPRO...
by Blazing, Michael A., MD
The American heart journal, 2014, Vol.168 (2), p.205-212.e1
45.
A VOYAGER Meta-Analysis of the Impact of Statin Therapy on Low-Density Lipoprotein Cholesterol and Triglyceride Levels in Patients With Hypertriglyceridemia
by Karlson, Björn W
The American journal of cardiology, 2016-05-01, Vol.117 (9), p.1444-1448
46.
Phenotypic Predictors of Response to Simvastatin Therapy Among African-Americans and Caucasians: The Cholesterol and Pharmacogenetics (CAP) Study
by Simon, Joel A
The American journal of cardiology, 2006, Vol.97 (6), p.843-850
47.
Simvastatin as an Adjunctive Therapy to Risperidone in Treatment of Autism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by Moazen-Zadeh, Ehsan
Journal of child and adolescent psychopharmacology, 2018-02-01, Vol.28 (1), p.82-89
48.
Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia
by Farnier, Michel, MD, PhD
The American heart journal, 2007, Vol.153 (2), p.335.e1-335.e8
49.
Simvastatin Protects against the Development of Endometriosis in a Nude Mouse Model
by Bruner-Tran, Kaylon L
The journal of clinical endocrinology and metabolism, 2009-07, Vol.94 (7), p.2489-2494
50.
Design and Baseline Characteristics of the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Study
by Rossebø, Anne B., MD
The American journal of cardiology, 2007, Vol.99 (7), p.970-973
51.
Eliminating drug resistant breast cancer stem-like cells with combination of simvastatin and gamma-tocotrienol
by Gopalan, Archana
Cancer letters, 2012, Vol.328 (2), p.285-296
52.
Genetic and Pharmacological Modulation of Akt1 for Improving Ovarian Graft Revascularization in a Mouse Model1
by Cohen, Yoni
Biology of reproduction, 2016-01, Vol.94 (1)
53.
Comparison of pitavastatin with simvastatin in primary hypercholesterolaemia or combined dyslipidaemia
by Ose, Leiv
Current medical research and opinion, 2009-11, Vol.25 (11), p.2755-2764
54.
Ezetimibe: Use, costs, and adverse events in Australia
by Hollingworth, Samantha A.
Cardiovascular therapeutics, 2017-02, Vol.35 (1), p.40-46
55.
Simvastatin Ameliorates Rat Cerebrovascular Remodeling During Hypertension via Inhibition of Volume-Regulated Chloride Channel
by Liu, Yu-Jie
Hypertension (Dallas, Tex. 1979), 2010-09, Vol.56 (3), p.445-452
56.
Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects
by Ayalasomayajula, Surya P
Current medical research and opinion, 2007-01, Vol.23 (12), p.2913-2920
57.
Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047
by FICHTENBAUM, Carl J
AIDS (London), 2002, Vol.16 (4), p.569-577
58.
Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial
by Green, Anders, MD, PhD, DrMedSci
The American journal of cardiology, 2014, Vol.114 (10), p.1518-1522
59.
The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterole...
by Florentin, Matilda
Current medical research and opinion, 2011-03, Vol.27 (3), p.685-692
60.
